Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said. ...
Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources. ...
Hyderabad-based pharmaceutical company Biological E on Monday received final approval from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax, for the age group 12 to 18 years. ...
Last year on January 16, India commenced the world's largest vaccination drive to vaccinate its massive population of around 1.38 billion against the COVID-19 infection. ...
The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine for children, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said. ...